Exact Mass: 920.3850546000001

Exact Mass Matches: 920.3850546000001

Found 15 metabolites which its exact mass value is equals to given mass value 920.3850546000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   
   

C50H64O16

NCGC00386109-01_C50H64O16_

C50H64O16 (920.4194143999999)


   

LPIM2 18:2

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-1-myo-inositol)

C39H69O22P (920.4017904)


   

gitoformate

gitoformate

C46H64O19 (920.4041594)


C - Cardiovascular system > C01 - Cardiac therapy > C01A - Cardiac glycosides > C01AA - Digitalis glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D004071 - Digitalis Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent

   
   

[(2R,3R,4S,6R)-3-[(2R,4R,5S,6S)-5-[(2S,4S,5R,6R)-4,5-diformyloxy-6-methyloxan-2-yl]oxy-4-formyloxy-6-methyloxan-2-yl]oxy-6-[[(3S,5R,8R,9S,10S,13R,14S,16S,17R)-16-formyloxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-2-methyloxan-4-yl] formate

[(2R,3R,4S,6R)-3-[(2R,4R,5S,6S)-5-[(2S,4S,5R,6R)-4,5-diformyloxy-6-methyloxan-2-yl]oxy-4-formyloxy-6-methyloxan-2-yl]oxy-6-[[(3S,5R,8R,9S,10S,13R,14S,16S,17R)-16-formyloxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-2-methyloxan-4-yl] formate

C46H64O19 (920.4041594)


   
   
   
   

LPIM2(18:2(9Z,12Z)/0:0)

LPIM2(18:2(9Z,12Z)/0:0)

C39H69O22P (920.4017904)


   

2-({1,2-dihydroxy-3-[(hydroxymethylidene)amino]propylidene}amino)-3-methyl-n-[(16z,17z,19e)-8,11,15,18-tetrahydroxy-16-(1h-indol-3-ylmethylidene)-2-(methoxymethyl)-9-methyl-4,5-dioxo-6-(sec-butyl)-23-thia-3,7,10,14,17,24-hexaazabicyclo[19.2.1]tetracosa-1(24),7,10,14,17,19,21-heptaen-12-yl]pentanimidic acid

2-({1,2-dihydroxy-3-[(hydroxymethylidene)amino]propylidene}amino)-3-methyl-n-[(16z,17z,19e)-8,11,15,18-tetrahydroxy-16-(1h-indol-3-ylmethylidene)-2-(methoxymethyl)-9-methyl-4,5-dioxo-6-(sec-butyl)-23-thia-3,7,10,14,17,24-hexaazabicyclo[19.2.1]tetracosa-1(24),7,10,14,17,19,21-heptaen-12-yl]pentanimidic acid

C43H56N10O11S (920.3850546000001)


   

4,15-bis[(4-hydroxy-3-methoxyphenyl)methyl]-5,16-bis[(4-hydroxyphenyl)methyl]-10,21-dimethyl-2,7,9,13,18,20-hexaoxatricyclo[17.3.1.1⁸,¹²]tetracosane-11,22,23,24-tetrol

4,15-bis[(4-hydroxy-3-methoxyphenyl)methyl]-5,16-bis[(4-hydroxyphenyl)methyl]-10,21-dimethyl-2,7,9,13,18,20-hexaoxatricyclo[17.3.1.1⁸,¹²]tetracosane-11,22,23,24-tetrol

C50H64O16 (920.4194143999999)